Drug Trial Radar · NCT04492020
Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants
Last checked: Nov 19, 2026Latest source record: May 31, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
518
Actual
Start
Aug 21, 2020
Primary completion
Apr 19, 2022
Study completion Apr 19, 2022
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Jul 30, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine When Administered During the Prodrome
Conditions
- Migraine
Interventions
Ubrogepant 100 mgDrug
For each qualifying prodrome event, 2 compressed tablets containing 50 mg of ubrogepant will be taken orally when the participant is confident that a headache will follow within 1-6 hours
PlaceboDrug
For each qualifying prodrome event, 2 compressed tablets containing placebo will be taken orally when the participant is confident that a headache will follow within 1-6 hours
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Reporting Absence of Headache of Moderate/Severe Intensity Within 24 Hours Post-doseTime frame: 24 hours after taking double-blind study intervention during the prodrome
Locations
73 sites in 1 country. Site status is shown where the registry gives one.
Achieve Clinical Research, LLC /ID# 237098
Birmingham, Alabama
Barrow Neuro Institute /ID# 236775
Phoenix, Arizona
Arkansas Clinical Research /ID# 238032
Little Rock, Arkansas
California Headache and Balance Center /ID# 236247
Fresno, California
Sun Valley Research Center /ID# 236561
Imperial, California
Wr-Pri Llc /Id# 236007
Los Alamitos, California
Pharmacology Research Institute (PRI) - Newport Beach (Wake) /ID# 237691
Newport Beach, California
Excell Research, Inc /ID# 237721
Oceanside, California
George J. Rederich M.D. Inc. /ID# 235769
Torrance, California
Diablo Clinical Research /ID# 237570
Walnut Creek, California
Colorado Springs Neurological Associates (CSNA) /ID# 236556
Colorado Springs, Colorado
Advanced Neurosciences Research, LLC /ID# 237426
Fort Collins, Colorado
CNS Healthcare - Jacksonville /ID# 238245
Jacksonville, Florida
Health Awareness, Inc - Jupiter /ID# 236226
Jupiter, Florida
Suncoast Clinical Research /ID# 236934
New Port Richey, Florida
Sensible Healthcare /ID# 238090
Ocoee, Florida
Clinical Neuroscience Solutions, Inc /ID# 236608
Orlando, Florida
Accel Research Sites - St Petersburg Clinical Research Unit /ID# 237163
St. Petersburg, Florida
University of South Florida /ID# 234387
Tampa, Florida
ForCare Clinical Research /ID# 237092
Tampa, Florida
Premiere Research Institute - Palm Beach /ID# 238193
West Palm Beach, Florida
NeuroTrials Research Inc. /ID# 237365
Atlanta, Georgia
iResearch Atlanta, LLC /ID# 237390
Decatur, Georgia
Meridian Clinical Research (Neurology) - Savannah /ID# 234371
Savannah, Georgia
Clinical Research Atlanta - Headlands LLC /ID# 234438
Stockbridge, Georgia
Northwest Clinical Trials /ID# 234968
Boise, Idaho
Deaconess Clinic Downtown /ID# 236959
Evansville, Indiana
PMG Research of McFarland /ID# 238271
Ames, Iowa
Collective Medical Research /ID# 236402
Overland Park, Kansas
Kansas Institute of Research /ID# 236738
Overland Park, Kansas
Boston Clinical Trials /ID# 236559
Boston, Massachusetts
Michigan Headache & Neurological Institute (MHNI) /ID# 236565
Ann Arbor, Michigan
Minneapolis Clinic of Neurology - Golden Valley /ID# 238162
Golden Valley, Minnesota
Clinical Research Institute, Inc /ID# 238301
Minneapolis, Minnesota
StudyMetrix Research /ID# 236457
City of Saint Peters, Missouri
Clinvest Research LLC /ID# 237908
Springfield, Missouri
Princeton Center for Clinical Research /ID# 235734
Skillman, New Jersey
Bio Behavioral Health, Inc /ID# 238212
Toms River, New Jersey
Dent Neurosciences Research Center, Inc. /ID# 237039
Amherst, New York
Central New York Clinical Research /ID# 235694
Manlius, New York
Showing 40 of 73 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.